GLP-1 Agonists: CV Outcomes Data in Type 2 Diabetes Published 2019-06-12 Download video MP4 360p Recommendations 09:56 The Story of GLP-1. "A diabetes doctor’s dream". Episode 1 05:22 Understanding the Role of GLP-1 Medicines in Managing Type 2 Diabetes 20:53 Updates and Unmet Needs in Primary Biliary Cholangitis: An HCPLive Special Report 13:54 Using GLP1 receptor agonists to treat cardiac patients with diabetes 02:51 Jeffrey Berger, MD: Deciding Between GLP1 Agonists or SGLT2 Inhibitors 1:13:00 Current Treatment Practices for Schizophrenia Spectrum Disorders 02:09 Dr Darren K. McGuire Discusses Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in T2D 08:09 Novel CSA Treatments with M. Safwan Badr, MD 04:38 How does sitagliptin work? DPP-4 inhibitors and GLP-1 mimetics 21:44 Dr. Paul Mason - 'The corrupt history of the food pyramid' 47:52 What is GLP-1, What Does It Do, and Where Does It Come From? with Dr. Ben Bikman 08:32 How Does Metformin Work? (Pharmacology for Nurses) 08:43 Advancements in Pediatric Psoriasis Treatment, with Lisa Swanson, MD 20:05 Dr. Paul Mason - 'The shady truth about statins' 01:32 How GLP-1 medications help you lose weight 05:09 Edward V Loftus, Jr, MD: Discussing FDA Approval of Risankizumab (Skyrizi) in Ulcerative Colitis 24:10 Dr. Maryanne Demasi - 'Statin Wars: Have we been misled by the evidence?' 03:55 MASH Management in Women 10:00 Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH 48:11 Brain Energy, Mitochondria, and Mental Health with Dr. Chris Palmer Similar videos 09:24 GLP-1 Agonists in T2D: Cardiovascular Outcomes Data 07:17 Cardiovascular Outcomes With GLP-1 Receptor Agonists in Type 2 Diabetes 05:05 SGLT2 Inhibitors: CV Outcomes Data in Type 2 Diabetes 39:11 Exploring Advances in GLP-1 Agonist Therapy 44:17 Cardiovascular Disease Burden in Type 2 Diabetes: Strategies to Improve Outcomes 1:29:07 Optimizing Cardiovascular Outcomes in Type 2 Diabetes: Beyond A1C Goals 58:42 Type 2 Diabetes: New Guidelines and Controversies 06:11 Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists 08:49 Mechanisms of Action of GLP-1 Agonists in T2D 04:47 GLP-1 Receptor Agonists and Cardiovascular Benefit 26:43 Prof Melanie Davies - 'Do GLP-1 analogues and SGLT2 inhibitors have a role beyond type 2 diabetes?' 02:38 GLP-1 Receptor Agonists: Initial Cardiovascular Evidence 03:50 Diabetes Drugs for Cardiovascular Risk 1:02:44 Exploring the Science and Practice of GLP-1 Receptor Agonists 40:56 Cardiovascular and Renal Outcomes in Type 2 Diabetes Medications with Dr. Marie McDonnell 18:44 Professor Lars Ryden - 'Are pleiotropic effects of GLP-1 agonists clinically important?' 50:30 Protocols for Safe Use of SGLT2i and GLP1RA in the Hospital Setting 14:53 Fundamentals of SGLT2i's and GLP-1RA's for CV Risk More results